Objective: To investigate whether hypnosis during ET contributes to successful IVF/ET outcome.
Design: Case-control clinical study.
Setting: Academic Fertility and IVF Unit, Soroka Medical Center, Beer-Sheva, Israel.
Thirty-five pregnancies were inadvertently conceived during the midluteal application of the long-acting gonadotropin-releasing hormone agonist triptorelin acetate before ovarian stimulation for in vitro fertilization. Most of the conceptions occurred before the first or second IVF trial, and were associated with a significantly increased tendency to develop gestational diabetes. No increase in pregnancy wastage or appearance of congenital malformations occurred.
View Article and Find Full Text PDF